Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant for Insomnia Comorbid Obstructive Sleep Apnea (COMISA)
ChiCTR2600129443Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Insomnia and obstructive sleep apnea hypopnea syndrome (OSAHS) comparing Daridorexant arm with Placebo arm (2 arms). Primary endpoint: Total Sleep Time (TST) by PSG at day 28. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
daridorexant
03
Conditions
Insomniaobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2600129443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129443.